Source comparison
Quickcomparison
Dose Range Relaxin-2 (Serelaxin) 1–10 mcg BPC-157 250–500 mcg Frequency Once daily Administration Intravenous (IV) infusion Subcutaneous injection Cycle Length 8-12 weeks 4-6 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Limited human trials Strong pre
This comparison does not assign a generated winner or score.
- Dose Range
- Relaxin-2 (Serelaxin)
- 1–10 mcg
- BPC-157
- 250–500 mcg
- Frequency
- Once daily
- Administration
- Intravenous (IV) infusion
- Subcutaneous injection
- Cycle Length
- 8-12 weeks
- 4-6 weeks
- Onset Speed
- Moderate (1-2 weeks)
- Evidence Level
- Limited human trials
- Strong preclinical (extensive animal studies)
- Efficacy